CJC-1295 vs Tesamorelin
Two GHRH analogues with different half-lives and research profiles.
What is the difference
CJC-1295 (without DAC) and Tesamorelin are both GHRH analogues studied in growth hormone research. The key difference is half-life: Tesamorelin has a longer profile and a distinct clinical trial record, while CJC-1295 without DAC is a shorter-acting research tool.
| Property | CJC-1295 (no DAC) | Tesamorelin |
|---|---|---|
| Type | GHRH analogue (short half-life) | GHRH analogue (longer half-life) |
| Clinical record | Preclinical / research tool | Phase 3 trial data available |
| Common format | 5 mg lyophilized powder | 5 mg lyophilized powder |
| Research focus | Pulsatile GH release studies | Sustained GH signalling studies |
| VND price | 1,000,000 VND | 1,500,000 VND |
Bottom line
Both are GHRH analogues but differ in half-life and research context. CJC-1295 without DAC is studied for pulsatile patterns; Tesamorelin for sustained signalling. Both in the catalog.
Ask about CJC-1295 (no DAC) or Tesamorelin
Format, price and timing confirmed before payment. Free swabs + syringe with every order.
Common questions
Which of these peptides is better for research?
Neither is "better" — CJC-1295 (no DAC) and Tesamorelin address different research questions through different mechanisms. The choice depends on the research protocol.
Can I order both peptides from this catalog?
Yes. CJC-1295 (no DAC) and Tesamorelin are listed as separate items. 2+ peptides = free bacteriostatic water 10 ml. Price and availability confirmed before payment.
Do I need a separate inquiry for each peptide?
No. You can ask about both in one Telegram message. Mention the names and formats — the manager will confirm availability, total and timing.